Imiquimod is the active ingredient in medications like Aldara, Zyclara, and others.It belongs to a class of drugs called immune response modifiers.
Treatment of actinic keratosis (precancerous skin lesions)
Treatment of superficial basal cell carcinoma (a type of skin cancer)
Treatment of genital warts (caused by the human papillomavirus, HPV)
Imiquad Cream (Imiquimod) works by stimulating the body's immune system to fight off the affected skin cells. It activates the immune system cells called T cells, which then destroy the abnormal cells.
Store the medication at room temperature, away from heat and moisture. Keep it out of the reach of children and pets.
The dosage and frequency of application will vary depending on the condition being treated and the specific product you are using.
Follow your doctor's instructions carefully.
Apply the medication as directed, typically once or twice a day.
Wash your hands thoroughly after applying the medication.
Redness, swelling, itching, and burning at the application site
Flulike symptoms (fever, chills, muscle aches)
Headache
Nausea
Fatigue
Lymphadenopathy (swollen lymph nodes)
Avoid excessive alcohol consumption while using imiquimod, as it can increase the risk of side effects.
Be careful while driving or operating machinery, as imiquimod can cause drowsiness or dizziness.
Imiquimod is not recommended for use during pregnancy or breastfeeding, as it may harm the fetus or infant. Discuss with your doctor before using this medication.
Imiquimod is not approved for use in children.
Imiquimod is not known to affect kidney function. However, it is important to inform your doctor if you have any kidney problems.
Imiquimod is not known to affect liver function. However, it is important to inform your doctor if you have any liver problems.
https://www.mayoclinic.org/diseases-conditions/actinic-keratosis/diagnosis-treatment/drc-20353504
https://www.ncbi.nlm.nih.gov/pubmed/12051459
https://www.fda.gov/drugs/drug-safety-and-availability/fda-drug-safety-communication-fda-approves-aldara-imiquimod-cream-5-treatment-superficial-basal-cell-carcinoma
